LINC01929 and cancer: Through immune infiltration analysis, it was found that the expression of LINC01929 is positively correlated with macrophages and negatively correlated with CD8 T cells in various tumours, which suggested that it may act as a modulator of immune evasion, a hallmark of cancer [31, 32, 33, 34].